Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Phagenesis Ltd.

Latest From Phagenesis Ltd.

Aimmune Gets $145m From Nestlé To Advance Food Allergy Immunotherapies

With the sizeable investment, Nestlé Health Sciences also gets a three-month right of first negotiation for licensing or partnering to develop any Aimmune candidates, including Phase III AR101 for peanut allergy.

Commercial Deals

M&A Deals Analysis: Big Bucks Are Back

September M&A deals picked up after a quiet summer with 23 M&A deals recorded, the busiest month of the year so far, which included two major deals closing at $4bn.

M & A Deals

New Products In Brief

InSightec, TriVascular and NicOx are among firms with notable recent product approvals or launches.

Medical Device

Phagenesis Ltd.

Many patients lose their ability to swallow normally following a stroke. Using alternative feeding routes and hoping that the swallowing function returns spontaneously are standard of care, which fails to address the root cause of the problem. Soon to become commercialized, though, is technology from Britain’s Phagenesis Ltd. that allows for electrical stimulation of the pharynx so that another part of the brain can take over the swallowing control function.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices